Abstract
Medicinal plants have long been used as an alternative in the treatment of diseases, whether using extracts, essential oils and / or bioactive components. Thus, the use of medicinal plants, with popularly known effects for the treatment of infections, has gained prominence, in research related to extracts and essential oils of medicinal plants, in an attempt to discover and future application of new molecules with antimicrobial and / or effect coadjuvant molecules to antimicrobials on the market. Studies with species of Melaleuca spp., Demonstrate wide application of its essential oil, without treating skin infections, microbial infections, herpes, diseases associated with pathogenic microorganisms of the oral cavity. The emerging microbial resistance to the drugs currently available on the market, has been affected by both researchers and the general population, so that the research experimented with was conducted revealing a high synergistic potential between drugs and natural drugs, present in drugs. In view of the above, this study aimed to present, through a bibliographic survey, a use of medicinal plants in the face of microbial resistance, as well as medicinal therapy based on the use of essential oils from alternative tea tree, leucadendron tea tree and quinquenervia tea tree, already inclusion in the literature.
Highlights
The use of therapeutic plants in medicines has been practiced for thousands of years, being used by most people in the world
M. quinquenervia leaves are a rich source of 1,8-cineol essential oil called Niaouli oil, which is used in pharmaceutical preparations for the relief of coughs and colds, rheumatism, neuralgia, and aromatherapy
The essential oil of Melaleuca spp. it can be an important ally of current medicine in combating multidrug-resistant pathogens
Summary
Authors: Thaís Rossini de Oliveira[1]; Anderson Laerte Teixeira[1]; Janaina Priscila Barbosa[1]; Simone N. Busato de Feiria[1]; Giovana C. Boni[1]; Flávia Maia[1]; Paula Cristina Anibal[1]; Gayan Kanchana Wijesinghe[1]; José Francisco Höfling1,A
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have